Skip to main content
. 2020 May 4;30(4):222–234. doi: 10.1089/cap.2019.0138

Table 3.

Severity of BPSS-P Items

 
Total (n = 76), median (Q1–Q3) BD-I (n = 24), median (Q1–Q3) BD-NOS (n = 29), median (Q1–Q3) MD-NOS (n = 23), median (Q1–Q3) p value Pairwise group comparison
  BD-I vs. BD-NOS BD-I vs. MD-NOS BD-NOS vs. MD-NOS
BPSS-P mania symptoms 4 (1–5) 5 (4–6) 4 (2–5) 3 (0–4) <0.0001 <0.0001 <0.0001 <0.0001
  1. Mood elevation 4 (3–5) 5 (5–6) 4 (3–5) 3 (1–4) <0.0001 <0.0001 <0.0001 0.009
  2. Irritability 5 (4.25–6) 5.5 (5–6) 5 (4.5–6) 5 (4–6) 0.081      
  3. Inflated self-esteem/grandiosity 2 (0–4) 4 (1.25–6) 1 (0–3.5) 1 (0–2) 0.001 0.004 0.001 n.s.
  4. Decreased need for sleep 3.5 (0–6) 5 (3.25–6) 3 (0–6) 0 (0–4) 0.003 n.s. 0.001 n.s.
  5. Over-talkativeness 5 (3–5) 5 (4–6) 5 (4–5) 3 (1–4) <0.0001 n.s. 0.001 <0.0001
  6. Racing thoughts/flight of ideas 4 (2–5) 5 (4.25–6) 4 (2–5) 2.5 (0.75–4) <0.0001 0.024 <0.0001 0.048
  7. Distractibility 5 (3–5) 5 (4–6) 5 (4–5) 4 (1–5) 0.01 n.s. 0.007 0.012
  8. Increased energy/goal-directed activity 3 (2–5) 5 (4–6) 3 (2–4) 1 (0–3) <0.0001 <0.0001 <0.0001 0.004
  9. Increased psychomotor activity 4 (3–5) 4 (4–6) 4 (2.5–5) 3 (1–4) 0.017 n.s. 0.005 n.s.
 10. Reckless or dangerous behavior 1.5 (0–5) 1 (0–4.75) 2 (0–5) 2 (0–4) 0.82      
BPSS-P depression symptoms 3 (0–5) 4 (1–5) 4 (1–5) 2 (0–4) <0.0001 n.s. <0.0001 <0.0001
  1. Depressed mood 5 (4–6) 6 (5–6) 5 (4–6) 4 (3–5) 0.004 n.s. <0.0001 0.022
  2. Anhedonia 4 (3–5) 5 (3.25–5) 4 (3–6) 3 (1.5–4) 0.006 n.s. 0.002 0.015
  3. Decreased appetite 1 (0–4) 1 (0–4) 2 (0–4) 0 (0-I) 0.026 n.s. 0.036 0.008
  4. Increased appetite 1 (0–3) 2 (0–4) 0 (0–3) 0 (0–2) 0.047 0.034 0.033 n.s.
  5. Insomnia 3 (0–5) 4 (0–5) 4 (2–5) 1 (0–4) 0.071      
  6. Hypersomnia 1 (0–3) 3 (0–5) 1 (0–3) 0 (0–3) 0.092      
  7. Decreased psychomotor activity 2 (0–4) 3 (3–5) 1 (0–4) 0 (0–2) 0.001 0.03 <0.0001 n.s.
  8. Decreased energy 4 (1–5) 4 (1–6) 5 (3.5–6) 2 (0–4) 0.017 n.s. n.s. 0.005
  9. Worthlessness/guilt 4 (1–5) 4 (2.5–5) 4 (3.5–5) 3 (0–5) 0.027 n.s. 0.031 0.013
 10. Decreased concentration 4 (1–5) 4.5 (2.25–5) 4 (3.25–5) 2 (0–4) 0.014 n.s. 0.016 0.007
 11. Indecision 2 (0–4) 2 (0.25–4.75) 2 (1–4) 1.5 (0–4) 0.350      
 12. Suicidality 6 (2–6) 5.5 (3–6) 6 (3–6) 4.5 (0–6) 0.185      
BPSS-P General symptoms 4 (0–5) 4 (0–5) 4 (1–5) 3 (1–5) 0.038 n.s. n.s. 0.011
  1. Mood lability 5 (3–6) 5 (4–6) 5 (4–6) 3 (0–5) 0.001 n.s. 0.002 0.001
  2. Oppositionality 3 (1.75–5) 3 (0–4) 3 (2–5) 4 (2–5) 0.513      
  3. Anger/aggressiveness 5 (3–5.5) 5 (3–6) 4 (3–5) 5 (3–5.25) 0.949      
  4. Anxiety 4 (2–5) 4.5 (3–5.75) 3.5 (1.75–5) 2 (1–5) 0.044 0.031 0.031 n.s.
  5. Self-injurious behavior 4 (0–5) 2.5 (0–4.75) 4 (0.5–6) 3 (0–4) 0.035 n.s. n.s. 0.012
  6. Obsessions and compulsions 0 (0–1) 0 (0–1) 0 (0–2) 0 (0–1) 0.959      

Bold values indicate p < 0.05 for between-groups analysis.

Severity is rated on an ordinal scale: 0 = absent, 1 = questionably present, 2 = mild, 3 = moderate, 4 = moderately severe, 5 = severe, 6 = extreme.

BD-I, bipolar disorder type I; BD-NOS, bipolar disorder not otherwise specified; BPSS-P, bipolar prodrome symptom scale-prospective; MD-NOS, mood disorder not otherwise specified; n.s., not significant; Q1, first quartile (P25); Q3, third quartile (P75).